338 related articles for article (PubMed ID: 29742168)
1. Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals.
Desheva Y; Sychev I; Smolonogina T; Rekstin A; Ilyushina N; Lugovtsev V; Samsonova A; Go A; Lerner A
PLoS One; 2018; 13(5):e0196771. PubMed ID: 29742168
[TBL] [Abstract][Full Text] [Related]
2. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
[TBL] [Abstract][Full Text] [Related]
3. Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies.
Gao J; Couzens L; Burke DF; Wan H; Wilson P; Memoli MJ; Xu X; Harvey R; Wrammert J; Ahmed R; Taubenberger JK; Smith DJ; Fouchier RAM; Eichelberger MC
mBio; 2019 Apr; 10(2):. PubMed ID: 30967460
[TBL] [Abstract][Full Text] [Related]
4. A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus.
Marcelin G; DuBois R; Rubrum A; Russell CJ; McElhaney JE; Webby RJ
PLoS One; 2011; 6(10):e26335. PubMed ID: 22039464
[TBL] [Abstract][Full Text] [Related]
5. Antigenicity of the 2015-2016 seasonal H1N1 human influenza virus HA and NA proteins.
Clark AM; DeDiego ML; Anderson CS; Wang J; Yang H; Nogales A; Martinez-Sobrido L; Zand MS; Sangster MY; Topham DJ
PLoS One; 2017; 12(11):e0188267. PubMed ID: 29145498
[TBL] [Abstract][Full Text] [Related]
6. Imprinted Anti-Hemagglutinin and Anti-Neuraminidase Antibody Responses after Childhood Infections of A(H1N1) and A(H1N1)pdm09 Influenza Viruses.
Daulagala P; Mann BR; Leung K; Lau EHY; Yung L; Lei R; Nizami SIN; Wu JT; Chiu SS; Daniels RS; Wu NC; Wentworth D; Peiris M; Yen HL
mBio; 2023 Jun; 14(3):e0008423. PubMed ID: 37070986
[TBL] [Abstract][Full Text] [Related]
7. Kinetics, Longevity, and Cross-Reactivity of Antineuraminidase Antibody after Natural Infection with Influenza A Viruses.
Changsom D; Jiang L; Lerdsamran H; Iamsirithaworn S; Kitphati R; Pooruk P; Auewarakul P; Puthavathana P
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29021304
[TBL] [Abstract][Full Text] [Related]
8. Association between Hemagglutinin Stem-Reactive Antibodies and Influenza A/H1N1 Virus Infection during the 2009 Pandemic.
Hoa LNM; Mai LQ; Bryant JE; Thai PQ; Hang NLK; Yen NTT; Duong TN; Thoang DD; Horby P; Werheim HFL; Fox A
J Virol; 2016 Jul; 90(14):6549-6556. PubMed ID: 27170747
[TBL] [Abstract][Full Text] [Related]
9. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
[TBL] [Abstract][Full Text] [Related]
10. [Formation of antibodies against neuraminidase of A/California/07/2009 (H1N1) influenza virus after immunization with live monovalent influenza vaccine].
Smolonogina TA; Desheva IuA; Shaldzhian AA; Grudinin MP; Rudenko LG
Zh Mikrobiol Epidemiol Immunobiol; 2011; (6):72-6. PubMed ID: 22308734
[TBL] [Abstract][Full Text] [Related]
11. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
[TBL] [Abstract][Full Text] [Related]
12. Use of lentiviral pseudotypes as an alternative to reassortant or Triton X-100-treated wild-type Influenza viruses in the neuraminidase inhibition enzyme-linked lectin assay.
Biuso F; Palladino L; Manenti A; Stanzani V; Lapini G; Gao J; Couzens L; Eichelberger MC; Montomoli E
Influenza Other Respir Viruses; 2019 Sep; 13(5):504-516. PubMed ID: 31411006
[TBL] [Abstract][Full Text] [Related]
13. Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase.
Couch RB; Atmar RL; Franco LM; Quarles JM; Wells J; Arden N; Niño D; Belmont JW
J Infect Dis; 2013 Mar; 207(6):974-81. PubMed ID: 23307936
[TBL] [Abstract][Full Text] [Related]
14. The 2009 pandemic H1N1 virus induces anti-neuraminidase (NA) antibodies that cross-react with the NA of H5N1 viruses in ferrets.
Chen Z; Kim L; Subbarao K; Jin H
Vaccine; 2012 Mar; 30(15):2516-22. PubMed ID: 22330124
[TBL] [Abstract][Full Text] [Related]
15. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
[TBL] [Abstract][Full Text] [Related]
16. Minor changes in the hemagglutinin of influenza A(H1N1)2009 virus alter its antigenic properties.
Strengell M; Ikonen N; Ziegler T; Julkunen I
PLoS One; 2011; 6(10):e25848. PubMed ID: 22022458
[TBL] [Abstract][Full Text] [Related]
17. Repeated Influenza Vaccination Boosts and Maintains H1N1pdm09 Neuraminidase Antibody Titers.
Hansen L; Zhou F; Amdam H; Trieu MC; Cox RJ
Front Immunol; 2021; 12():748264. PubMed ID: 34721417
[TBL] [Abstract][Full Text] [Related]
18. HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains.
Luytjes W; Enouf V; Schipper M; Gijzen K; Liu WM; van der Lubben M; Meijer A; van der Werf S; Soethout EC
Vaccine; 2012 Jul; 30(35):5262-9. PubMed ID: 22691431
[TBL] [Abstract][Full Text] [Related]
19. Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses.
Koel BF; Mögling R; Chutinimitkul S; Fraaij PL; Burke DF; van der Vliet S; de Wit E; Bestebroer TM; Rimmelzwaan GF; Osterhaus AD; Smith DJ; Fouchier RA; de Graaf M
J Virol; 2015 Apr; 89(7):3763-75. PubMed ID: 25609810
[TBL] [Abstract][Full Text] [Related]
20. Elicitation of Broadly Protective Antibodies following Infection with Influenza Viruses Expressing H1N1 Computationally Optimized Broadly Reactive Hemagglutinin Antigens.
Sautto GA; Kirchenbaum GA; Ecker JW; Bebin-Blackwell AG; Pierce SR; Ross TM
Immunohorizons; 2018 Aug; 2(7):226-237. PubMed ID: 31022693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
